IOVA Abuzz, SUPN Study Flops, IMV Plunges Despite Positive Ovarian Cancer Data

Today’s Daily Dose brings you news about IMV’s ovarian cancer trial results, reports of Iovance considering a possible sale, Nemaura’s head -to-head study with a major Glucose Monitoring System, and disappointing trial results of Vanda and Supernus. RTT – Top … Read more…